Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Business Models and Strategy

 

HBI 2020: The future of domiciliary homecare – meeting an insatiable demand

In many markets there is a growing, perhaps even an insatiable demand for unskilled homecare. Is it a sector where it is possible to make money, and how? Is reimbursement sufficient? How do you attract and retain staff? And what effect is COVID having on the market? An expert panel at HBI 2020 considered all this, together with the biggest risks, and best opportunities, as we all dare to look forward to a more normal life in 2021.

HBI 2020: Investor interest in hospitals increases while outpatient valuations drop

Investors from varied backgrounds - infrastructure, private equity, and REIT, are all bullish about the prospects for healthcare investment in 2021, according to a panel of experts speaking at the HBI 2020 European Investment Panel discussion. But the pandemic may have 'readjusted the relative value discussion across sectors' according to one private equity investor.

Interview: Dr Peter Byloos, Optegra

As HBI reported last week, UK, Czechia and Poland-based ophthalmology platform Optegra Eye Health Care is being acquired by H2 Equity Partners. HBI caught up with Optegra CEO Dr Peter Byloos to hear his views on the market (and inevitably these days, the impact of COVID), and to find out about Optegra’s plans under new ownership. 

Operators in Russia and ex-CIS hit hard by COVID

State financing has seen little growth in expenditure in Russia over the last couple of years, while former CIS countries are struggling to fund robust healthcare systems. Despite this, panellists at HBI's Russia and Former CIS - State of the Regions discussion last week found some reasons to be positive.

Interview: Javier Román, CEO, Clece

Clece is one of Spain's largest homecare providers and is also present in the UK, with total domiciliary care sales of over €400m in 2019. HBI gets a snapshot of the business and its views on sector challenges from CEO Javier Román.

Dentex gets cash injection from shareholder

In what has been a tough year for dentists across Europe, UK dental partnership group Dentex has raised a further £20m from its major shareholder "to continue success in the corporate dental world". HBI speaks to CEO Barry Lanesman to find out more.

Interview: Massimiliano Colella, CEO, Evercare Group

We talk to the CEO of Evercare Group, the diverse conglomerate of South Asia and African hospitals that make up the $1bn Evercare Health Fund originally raised by Abraaj before TPG's takeover in 2019. Colella talks strategic priorities including 'turning Evercare from a fund into a real company', recent management departures, the platform today and why his own lack of emerging market healthcare service experience doesn't matter for this job.

Analysis: which listed care providers are recovering best?

Why are listed Nordic care providers' share prices seeing a faster recovery than other European counter parts? And how has each operator weathered the storm? HBI takes a deep dive into the financials to deliver an exclusive analysis as providers prepare their Q3 results.

Addiction treatment for the mass market

UK Addiction Treatment claims 97% occupancy within a week of opening its latest facility. But would you invest in a business run by addicts for addicts? Or whose majority investor, Global Group, has recently seen its founder, Greg Lindbergh, jailed for bribing a US official? We talk to UKAT CEO, Eytan Alexander.

Find Us